Systemic therapies for endometrial carcinoma

Brian Slomovitz, Karen H. Lu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Because of the hematogenous and lymphatic spread of endometrial cancer (EC), patients with recurrent or advanced disease often present with tumor outside of the pelvis. Systemic therapy, therefore, plays an important role in the management of these patients. Both hormonal and cytotoxic agents have activity in patients with advanced or recurrent EC. However, neither of these types of therapies is considered curative in patients with distant, metastatic disease.

Original languageEnglish (US)
Title of host publicationCancer of the Uterus
PublisherCRC Press
Pages407-434
Number of pages28
ISBN (Electronic)9780849377884
ISBN (Print)0824754158, 9780824754150
StatePublished - Jan 1 2004
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Slomovitz, B., & Lu, K. H. (2004). Systemic therapies for endometrial carcinoma. In Cancer of the Uterus (pp. 407-434). CRC Press.